Back to Agenda
How to Build a Sustainable Pharmacovigilance Ecosystem?
Session Chair(s)
Jan Petracek, MD, MSc
CEO
Ivigee, Czech Republic
James Whitehead, MBA, MSc
Senior Director, Device & Digital Safety
AstraZeneca, United Kingdom
Esther De Vries, MS, MSc
Pharmacovigilance Assessor
CBG-MEB, Netherlands
Is the current pharmacovigilance and patient safety ecosystem sustainable? Using the themes of people, technology and regulations, this collaborative session will explore the changes that the community feels need to occur for how we operate to become sustainable. Led by three members of the community, participants will be allocated to one of three themes and guided through an exercise to understand the as-is, ideation of the future state and define the changes. All participants of this interactive session will receive the output, which can be used as a stimulus for change in their area of Pharmacovigilance and Patient Safety.
Learning Objective : Recognise the opportunities for implementing the new ecosystem in pharmacovigilance, including driving factors, technology enablers and talent needs. Propose strategies to overcome recognised obstacles to achieve sustainability which enables win-win scenarios for all stakeholders. Predict future developments to be ready for upcoming changes.
Have an account?